Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers' Super Bowl ad plugs its compounded weight loss drugs as the "affordable" solution to a "sick system," but many ...

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access.

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you're starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food and Drug ...

Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics two hormones in the gut that help regulate blood sugar, reduce hunger cues and slow digestion. It’s the active ingredient in the ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

When Tina Jacobson tried to get Ozempic to lose weight, her health insurance provider denied coverage because she was not diabetic. Instead of paying more than $1,000 out of pocket for the Type 2 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

“In a world full of choices, we should ALL have the choice to use what we and our doctors feel is best for our bodies,” said Jami W. of Afton, Wyoming. Jami is one of millions of women in the U.S. who ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Patients are being hospitalized with severe complications after ...

Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved versions of its drugs Wegovy and Ozempic. Amid shortages and rising demand for ...